Peter Attia· MD
there are some really exciting developments in terms of looking at blood biomarkers including plasma amyloid in terms of potentially having a blood-based test for alzheimer's
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
there are some really exciting developments in terms of looking at blood biomarkers including plasma amyloid in terms of potentially having a blood-based test for alzheimer's
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
so you know there are some really exciting i don't want to forget about your tau questions um you know there are some really exciting developments in terms of looking at blood biomarkers including plasma amyloid um in terms of potentially having a blood-based test for alzheimer's so there has been progress there
but overall we get a pretty darn good way to handicap someone's risk of alzheimer's disease